Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2025 16:05 ET | Source: Nutriband Inc.

Nutriband Inc. to Present at the MicroCap Rodeo Conference

ORLANDO, Fla., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (The Company) (Nasdaq:NTRB) (Nasdaq: NTRBW), announces it will participate in the MicroCap Rodeo Conference, to be held Thursday,...
September 16, 2025 07:00 ET | Source: AccuStem Sciences, Inc.

AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th

PHOENIX and LONDON, Sept. 16, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of...
September 10, 2025 09:15 ET | Source: Nutriband Inc.

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Q2 results
September 04, 2025 16:05 ET | Source: TISSIUM

TISSIUM Advances Clinical Pipeline in Hernia Repair Following First FDA Authorization

Paris, France, Cambridge, USA, September 4 2025 - TISSIUM, a MedTech company pioneering biomorphic programmable polymers for tissue reconstruction, today announced further progress in its clinical...
September 03, 2025 16:01 ET | Source: Nutriband Inc.

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

warrant conversion
September 03, 2025 09:20 ET | Source: PharmAla Biotech

PharmAla Incorporates Australian Entity for Clinical Research

PharmAla incorporates a new entity in Australia to take advantage of tax incentives, and appoints Dr. Evan Lewis to its clinical advisory board.
August 27, 2025 07:00 ET | Source: Treos Bio Corp.

TREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal Cancer

LONDON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- TREOS Bio Ltd., a clinical-stage biotechnology company developing next-generation off-the-shelf peptide cancer immunotherapies, today announced the...
August 18, 2025 09:00 ET | Source: Nutriband Inc.

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Presentation announcement
August 14, 2025 08:30 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy

BOSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its...
August 11, 2025 09:00 ET | Source: Tiziana Life Sciences Ltd.

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...